These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Prostanoids in the treatment of pulmonary arterial hypertension]. Başkurt M; Küçükoğlu MS Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749 [TBL] [Abstract][Full Text] [Related]
6. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Olschewski H; Rose F; Schermuly R; Ghofrani HA; Enke B; Olschewski A; Seeger W Pharmacol Ther; 2004 May; 102(2):139-53. PubMed ID: 15163595 [TBL] [Abstract][Full Text] [Related]
11. Prostanoids for pulmonary arterial hypertension. Galiè N; Manes A; Branzi A Am J Respir Med; 2003; 2(2):123-37. PubMed ID: 14720012 [TBL] [Abstract][Full Text] [Related]
12. Inhaled iloprost for the control of pulmonary hypertension. Krug S; Sablotzki A; Hammerschmidt S; Wirtz H; Seyfarth HJ Vasc Health Risk Manag; 2009; 5(1):465-74. PubMed ID: 19475782 [TBL] [Abstract][Full Text] [Related]
13. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735 [TBL] [Abstract][Full Text] [Related]
14. Cellular pathophysiology and therapy of pulmonary hypertension. Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283 [TBL] [Abstract][Full Text] [Related]
15. Inhaled iloprost for the treatment of pulmonary hypertension. Olschewski H Eur Respir Rev; 2009 Mar; 18(111):29-34. PubMed ID: 20956120 [TBL] [Abstract][Full Text] [Related]
16. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Olschewski H; Ghofrani HA; Schmehl T; Winkler J; Wilkens H; Höper MM; Behr J; Kleber FX; Seeger W Ann Intern Med; 2000 Mar; 132(6):435-43. PubMed ID: 10733442 [TBL] [Abstract][Full Text] [Related]
17. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. Voswinckel R; Enke B; Reichenberger F; Kohstall M; Kreckel A; Krick S; Gall H; Gessler T; Schmehl T; Ghofrani HA; Schermuly RT; Grimminger F; Rubin LJ; Seeger W; Olschewski H J Am Coll Cardiol; 2006 Oct; 48(8):1672-81. PubMed ID: 17045906 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension. de Jesus Perez VA; Rosenzweig E; Rubin LJ; Poch D; Bajwa A; Park M; Jain M; Bourge RC; Kudelko K; Spiekerkoetter E; Liu J; Hsi A; Zamanian RT Am J Cardiol; 2012 Nov; 110(10):1546-50. PubMed ID: 22853986 [TBL] [Abstract][Full Text] [Related]
19. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors. Schermuly RT; Inholte C; Ghofrani HA; Gall H; Weissmann N; Weidenbach A; Seeger W; Grimminger F Respir Res; 2005 Jul; 6(1):76. PubMed ID: 16033645 [TBL] [Abstract][Full Text] [Related]
20. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs. Safdar Z Respir Med; 2011 Jun; 105(6):818-27. PubMed ID: 21273054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]